Osiris Announces Milestone Payment in Diabetes Treatment
The adult stem cell company Osiris Therapeutics today announced the achievement of a milestone payment in the progress of its adult stem cell therapy for the treatment of Type I diabetes.
The adult stem cell company Osiris Therapeutics today announced the achievement of a milestone payment in the progress of its adult stem cell therapy for the treatment of Type I diabetes.
The stem cell company Bioheart has announced FDA authorization to begin Phase I clinical trials for the use of adult stem cells in the treatment of heart failure.
The state of Nebraska has awarded grants to three of its universities for nonembryonic stem cell research.
Doctors in Mumbai use autologous adult stem cells to treat multiple myeloma.
A Federal Circuit judge has issued a ruling that settles a stem cell patent dispute.
Scientists in London are one step closer to developing replacement bone from adult stem cells.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.